| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome
|
Pagidipati, Neha J.
|
|
2017
|
187 |
C |
p. 53-61
9 p.
|
artikel
|
| 2 |
Assessing MICRO-vascular resistances via IMR to predict outcome in STEMI patients with multivessel disease undergoing primary PCI (AMICRO): Rationale and design of a prospective multicenter clinical trial
|
Fineschi, Massimo
|
|
2017
|
187 |
C |
p. 37-44
8 p.
|
artikel
|
| 3 |
Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study
|
Bagai, Akshay
|
|
2017
|
187 |
C |
p. 19-28
10 p.
|
artikel
|
| 4 |
Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial
|
Diederichsen, Søren Zöga
|
|
2017
|
187 |
C |
p. 122-132
11 p.
|
artikel
|
| 5 |
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
|
Mentz, Robert J.
|
|
2017
|
187 |
C |
p. 1-9
9 p.
|
artikel
|
| 6 |
β-Blocker after acute myocardial infarction
|
Kawada, Tomoyuki
|
|
2017
|
187 |
C |
p. e1-
1 p.
|
artikel
|
| 7 |
Clinical decision support for stroke prevention in atrial fibrillation (CDS-AF): Rationale and design of a cluster randomized trial in the primary care setting
|
Karlsson, Lars O.
|
|
2017
|
187 |
C |
p. 45-52
8 p.
|
artikel
|
| 8 |
Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines–Coronary Artery Disease (GWTG-CAD) program
|
Deedwania, Prakash
|
|
2017
|
187 |
C |
p. 78-87
10 p.
|
artikel
|
| 9 |
Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial
|
Pang, Peter S.
|
|
2017
|
187 |
C |
p. 62-69
8 p.
|
artikel
|
| 10 |
Determinants of operator radiation exposure during percutaneous coronary procedures
|
Sciahbasi, Alessandro
|
|
2017
|
187 |
C |
p. 10-18
9 p.
|
artikel
|
| 11 |
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndrome
|
Hess, Connie N.
|
|
2017
|
187 |
C |
p. 194-203
10 p.
|
artikel
|
| 12 |
Editorial Board
|
|
|
2017
|
187 |
C |
p. v-
1 p.
|
artikel
|
| 13 |
Factors associated with rhythm control treatment decisions in patients with atrial fibrillation—Insights from the NCDR PINNACLE registry
|
Gehi, Anil K.
|
|
2017
|
187 |
C |
p. 88-97
10 p.
|
artikel
|
| 14 |
Information for Readers
|
|
|
2017
|
187 |
C |
p. vi-
1 p.
|
artikel
|
| 15 |
Letter to Editor
|
Elbadawi, Ayman
|
|
2017
|
187 |
C |
p. e5-
1 p.
|
artikel
|
| 16 |
Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium
|
Piccini, Jonathan P.
|
|
2017
|
187 |
C |
p. 156-169
14 p.
|
artikel
|
| 17 |
Managing subfertility in patients with heart disease: What are the choices?
|
Cauldwell, Matthew
|
|
2017
|
187 |
C |
p. 29-36
8 p.
|
artikel
|
| 18 |
Percutaneous revascularization in patients treated with thoracic radiation for cancer
|
Fender, Erin A.
|
|
2017
|
187 |
C |
p. 98-103
6 p.
|
artikel
|
| 19 |
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)—A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics
|
Landray, M.J.
|
|
2017
|
187 |
C |
p. 182-190
9 p.
|
artikel
|
| 20 |
Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems–Biology for Promotion of Health (FAMILIA)
|
Bansilal, Sameer
|
|
2017
|
187 |
C |
p. 170-181
12 p.
|
artikel
|
| 21 |
Rationale and design of the Japan-USA harmonized assessment by randomized, multicenter study of OrbusNEich's combo StEnt (Japan-USA HARMONEE): Assessment of a novel DES platform for percutaneous coronary revascularization in patients with ischemic coronary disease and non–ST-elevation acute coronary syndrome
|
Kong, David F.
|
|
2017
|
187 |
C |
p. 112-121
10 p.
|
artikel
|
| 22 |
Recurrent MI and stroke post–acute coronary syndrome: Which is the lesser evil?
|
Lavi, Shahar
|
|
2017
|
187 |
C |
p. 191-193
3 p.
|
artikel
|
| 23 |
Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial
|
Lemmert, Miguel E.
|
|
2017
|
187 |
C |
p. 104-111
8 p.
|
artikel
|
| 24 |
Reply to comment by Elbadawi et al
|
Verouhis, Dinos
|
|
2017
|
187 |
C |
p. e7-e8
nvt p.
|
artikel
|
| 25 |
Response to letter to the editor by Dr Tomoyuki Kawada
|
Allen, Jason E.
|
|
2017
|
187 |
C |
p. e3-
1 p.
|
artikel
|
| 26 |
Table of Contents
|
|
|
2017
|
187 |
C |
p. i-iv
nvt p.
|
artikel
|
| 27 |
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial
|
Ho, Carolyn Y.
|
|
2017
|
187 |
C |
p. 145-155
11 p.
|
artikel
|
| 28 |
Time to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgery
|
Arendt, Christopher J.
|
|
2017
|
187 |
C |
p. 70-77
8 p.
|
artikel
|
| 29 |
Toward evidence-based diagnosis of myocarditis in children and adolescents: Rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform
|
Messroghli, Daniel R.
|
|
2017
|
187 |
C |
p. 133-144
12 p.
|
artikel
|
Tijdschrift beschrijving